[1]唐思魏,王蕾,陆斌,等.电生理监测在原发性面肌痉挛MVD中的应用[J].中国临床神经外科杂志,2023,28(12):689-692.[doi:10.13798/j.issn.1009-153X.2023.12.005]
 TANG Si-wei,WANG Lei,LU Bin,et al.Clinical value of intraoperative neuroelectrophysiological monitoring in microvascular decompression for patients with primary hemifacial spasm[J].,2023,28(12):689-692.[doi:10.13798/j.issn.1009-153X.2023.12.005]
点击复制

电生理监测在原发性面肌痉挛MVD中的应用()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年12期
页码:
689-692
栏目:
论著
出版日期:
2023-12-31

文章信息/Info

Title:
Clinical value of intraoperative neuroelectrophysiological monitoring in microvascular decompression for patients with primary hemifacial spasm
文章编号:
1009-153X(2023)12-0689-04
作者:
唐思魏王蕾陆斌姜文博吴国庆
266071山东青岛,康复大学青岛医院(青岛市市立医院)神经外科(唐思魏、陆斌、姜文博、吴国庆),门诊部(王蕾)
Author(s):
TANG Si-wei WANG Lei LU Bin JIANG Wen-bo WU Guo-qing
Department of Neurosurgery, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao 266071, China
关键词:
原发性面肌痉挛显微血管减压术术中神经电生理监测疗效并发症
Keywords:
Primary facial spasm Microvascular decompression Intraoperative electrophysiological monitoring Efficacy Postoperative complications
分类号:
R 745.1+2; R 651.1+1
DOI:
10.13798/j.issn.1009-153X.2023.12.005
文献标志码:
A
摘要:
目的 探讨电生理监测在原发性面肌痉挛(HFS)显微血管减压术(MVD)中的应用价值。方法 回顾性分析2012年1月至2022年9月MVD治疗的304例HFS的临床资料。103例(监测组)术中监测侧方扩散波(LSR)、脑干听觉诱发电位(BAEP)和面神经自由肌电图(EMG),201例(对照组)术中未使用电生理监测。术后6个月按照Cohen痉挛强度分级评估疗效;术后1周、6个月记录面瘫、耳鸣、眩晕、听力受损等并发症情况。结果 103例中,95例面神经充分减压后,LSR完全消失,7例LSR波幅下降>50%,1例LSR波幅下降不明显;2例BAEP出现Ⅰ波波幅下降>50%,1例出现Ⅲ波潜伏期延长超过20%;61例术中监测到面神经EMG,其中波幅<100 μV有54例,100~200 μV有7例。术后6个月,监测组有效率(93.03%)与对照组(94.17%)无统计学差异(P>0.05)。术后1周,对照组面瘫(12.43%)、耳鸣(13.43%)、眩晕(20.40%)、听力受损(13.43%)发生率明显高于监测组(分别为4.85%、5.83%11.65%、4.85%;P<0.05)。术后6个月,对照组耳鸣(8.46%)、眩晕(11.44%)、听力受损(9.00%)发生率仍明显高于监测组(分别为1.94%、3.88%、1.94%;P<0.05);但对照组面瘫发生率(3.00%)与监测组(1.00%)无统计学差异(P>0.05)。结论 MVD是治疗HFS的有效方法,术中应用神经电生理监测技术,可帮助尽早准确判断责任血管,减少对神经和脑组织的牵拉,减少术后并发症。
Abstract:
Objective To investigate the application value of intraoperative electrophysiological monitoring (IEM) in microvascular decompression (MVD) for patients with primary hemifacial spasm (HFS). Methods The clinical data of 304 patients with primary HFS treated with MVD from January 2012 to September 2022 were retrospectively analyzed. Lateral spread response (LSR), brainstem auditory evoked potential (BAEP) and electromyography (EMG) of the facial nerve were performed in 103 patients during the operation (monitoring group), and did not in 201 patients (control group). Six months after operation, the efficacy was evaluated according to Cohen spasm grading. Complications such as facial paralysis, tinnitus, vertigo and hearing loss were recorded 1 week and 6 months after operation. Results LSR disappeared completely after decompression of the facial nerve in 95 patients, LSR amplitude decreased by >50% in 7, and LSR amplitude decreased not significantly in 1. The amplitude of wave Ⅰ of BAEP decreased by more than 50% in 2 patients, and the latency of wave Ⅲ increased by more than 20% in 1. Facial nerve EMG was detected in 61 patients( amplitude <100 μV in 54 patients, 100~200 μV in 7). There was no significant difference in the effective rate between the monitoring group (93.03%) and the control group (94.17%; P>0.05) 6 months after operation. One week after operation, the rates of facial palsy (12.43%), tinnitus (13.43%), vertigo (20.40%) and hearing loss (13.43%) in the control group were significantly higher than those (4.85%, 5.83%, 11.65%, 4.85%, respectively) in the monitoring group (P<0.05). Six months after operation, the rates of tinnitus (8.46%), vertigo (11.44%) and hearing loss (9.00%) in the control group was still significantly higher than those (1.94%, 3.88% and 1.94%, respectively) in the monitoring group (P<0.05); however, there was no significant difference in the incidence of facial palsy between the control group (3.00%) and the monitoring group (1.00%; P>0.05). Conclusions MVD is effective for primary HFS. The application of IEM can help to identify the responsible vessels, reduce the injury of nerve and brain tissues, and reduce postoperative complications.

参考文献/References:

[1]JIANG CQ, WANG Z, ZHOU D, et al. Clinical diagnosis and treatment analysis of 553 cases of acoustic neuroma in a single center [J]. Chin Med J(Engl), 2021, 101(26): 2077-2080.
[2]YUE H, ZHOU M, CHONG Y, et al. Effects of lidocaine on motor-evoked potentials and somatosensory-evoked potentials in patients undergoing intraspinal tumour resection: study protocol for a prospective randomized controlled trial [J]. J Pain Res, 2022, 15: 287-297.
[3]SHIMANSKY VN, OGURTSOVA AA, POSHATAEV VK, et al. Early results of intraoperative neurophysiological monitoring in surgical treatment of hemifacial spasm [J]. Zh Vopr Neirokhi Im N N Burdenko, 2023, 87(3): 56-64.
[4]上海交通大学颅神经疾病诊疗中心. 面肌痉挛诊疗中国专家共识[J]. 中国微侵袭神经外科杂志,2014,19(11): 528-532.
[5]FUKUDA M. Intraoperative monitoring during microvascular decompression for hemifacial spasm [J]. No Shinkei Geka, 2023, 51(3): 525-532.
[6]SHIMANO H, KONDO A, YASUDA S, et al. Microvascular decompression for hemifacial spasm associated with bilateral vertebral artery compression [J]. World Neurosurg, 2015, 84(4): 1178.e5-9.
[7]LI F, SONG H, LIANG J, et al. Analysing correlation between the facial nerve notch at the root exit zone and long-term effect in patients with hemifacial spasm after microvascular decompression: a prospective study [J]. Neurol India, 2022, 70(5): 1819-1823.
[8]SUN C, XU J, ZHU W, et al. Beyond the observation of all or nothing: the clinical significance of the pre-decompression instability of abnormal muscle response in microvascular decompression for hemifacial spasm [J]. J Clin Neurosci, 2022, 104: 64-68.
[9]EL DAMATY A, ROSENSTENGEL C, MATTHES M, et al. The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients [J]. Neurosurg Rev, 2016, 39(3): 455-466.
[10]EL DAMATY A, ROSENSTENGEL C, MATTHES M, et al. Lateral spread response monitoring during microvascular decompression for hemifacial spasm: comparison of two targets of partial neuromuscular blockade [J]. Anaesthesist, 2014, 63(2): 122-128.
[11]中国医师协会神经外科医师分会. 中国神经外科术中电生理监测规范[J]. 中华医学杂志,2018,98(17):1283-1293.
[12]THIRUMALA PD, KRISHNAIAH B, HABEYCH ME, et al. Hearing outcomes after loss of brainstem auditory evoked potentials during microvascular decompression [J]. J Clin Neurosci, 2015, 22(4): 659-663.
[13]JIANG S, LANG L, SUN B, et al. Reoperation for residual or recurrent hemifacial spasm after microvascular decompression [J]. Acta Neurochir(Wien), 2022, 164(11): 2963-2973.

相似文献/References:

[1]武广永 张志宇 刘 志 周景儒 王栋梁 焦 风 刘如恩.单侧咀嚼肌痉挛的显微手术治疗(附7例分析[J].中国临床神经外科杂志,2017,(12):808.[doi:10.13798/j.issn.1009-153X.2017.12.003]
 WU Guang-yong,ZHANG Zhi-yu,LIU Zhi,et al.Curative effect of different surgical methods on unilateral masticatory muscle spasm (report of 7 cases)[J].,2017,(12):808.[doi:10.13798/j.issn.1009-153X.2017.12.003]
[2]关 锋,赵卫国,濮春华,等.面肌痉挛微血管减压术后听力障碍的影响因素[J].中国临床神经外科杂志,2019,(06):330.[doi:10.13798/j.issn.1009-153X.2019.06.004]
 GUAN Feng,ZHAO Wei-guo,PU Chun-hua,et al.Risk factors of hearing loss following microvascular decompression for primary hemifacial spasm[J].,2019,(12):330.[doi:10.13798/j.issn.1009-153X.2019.06.004]
[3]王凤伟 杨金庆 薛 勇.神经电生理监测在原发性面肌痉挛微血管减压术中的应用[J].中国临床神经外科杂志,2019,(08):483.[doi:10.13798/j.issn.1009-153X.2019.08.011]
 WANG Feng-wei,YANG Jin-qing,XUE Yong.Application of neuroelectrophysiological monitoring in microvascular decompression for primary hemifacial spasm[J].,2019,(12):483.[doi:10.13798/j.issn.1009-153X.2019.08.011]
[4]王文雄 成 睿 综述 张刚利 审校.弥散张量成像辅助面肌痉挛治疗研究进展[J].中国临床神经外科杂志,2020,(05):331.[doi:10.13798/j.issn.1009-153X.2020.05.026]
[5]张琼 卢思言 综述 苗重昌 审校.原发性三叉神经痛的诊断与治疗进展[J].中国临床神经外科杂志,2020,(06):411.[doi:10.13798/j.issn.1009-153X.2020.06.025]
[6]马召儒 王晓嵩 魏晓明 薛祎腾 刘 利.显微血管减压术治疗老年原发性三叉神经痛的疗效[J].中国临床神经外科杂志,2020,(08):554.[doi:10.13798/j.issn.1009-153X.2020.08.019]
[7]郝海涛 白亚辉 占益平.神经内镜辅助显微血管减压术治疗MRTA阴性原发性三叉神经痛的疗效[J].中国临床神经外科杂志,2021,26(07):515.[doi:10.13798/j.issn.1009-153X.2021.07.006]
 HAO Hai-tao,BAI Ya-hui,ZHAN Yi-ping..Neuroendoscopy assisted microvascular decompression for patients with MRTA negative primary trigeminal neuralgia[J].,2021,26(12):515.[doi:10.13798/j.issn.1009-153X.2021.07.006]
[8]万 群 杜晓亮 王明明等.神经内镜在面肌痉挛微血管减压术中的应用进展[J].中国临床神经外科杂志,2021,26(11):884.[doi:10.13798/j.issn.1009-153X.2021.11.022]
[9]章钟鼎 方黄毅 庞 晨等.微血管减压术治疗三叉神经痛、面肌痉挛44例[J].中国临床神经外科杂志,2021,26(12):950.[doi:10.13798/j.issn.1009-153X.2021.12.018]
[10]张显峰 王先锋 刘明峰等.原发性面肌痉挛微血管减压术后继发脑出血、脑积水1例[J].中国临床神经外科杂志,2021,26(12):974.[doi:10.13798/j.issn.1009-153X.2021.12.028]
[11]姜成荣 徐 武 王 晶 虞 晨 程龙阳 梁维邦.显微血管减压术治疗原发性面肌痉挛合并原发性三叉神经痛的疗效分析[J].中国临床神经外科杂志,2021,26(08):590.[doi:10.13798/j.issn.1009-153X.2021.08.006]
 JIANG Cheng-rong,XU Wu,WANG Jing,et al.Microvascular decompression for patients with primary hemifacial spasm associated with primary trigeminal neuralgia[J].,2021,26(12):590.[doi:10.13798/j.issn.1009-153X.2021.08.006]

备注/Memo

备注/Memo:
(2023-05-15收稿,2023-09-20修回)
通讯作者:吴国庆,E-mail:ns-wgq@163.com
更新日期/Last Update: 2023-12-31